<i id='04D9593663'><strike id='04D9593663'><tt id='04D9593663'><pre id='04D9593663'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
How to save PrEP access — and even expand it 
Study: Lilly Alzheimer's therapy slowed patients' cognitive decline 
BioMarin wins approval for gene therapy to treat hemophilia A 
Prime Medicine, Myeloid Therapeutics clash over genome 
Biden outlines 'new path' to provide student loan relief after Supreme Court rejection 
Why health care costs have stayed mostly flat since 2010 
What does generative AI mean for health care? We asked experts 
Medicare drug price negotiation hasn't dried up venture capital 
New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Study: Lilly Alzheimer's therapy slowed patients' cognitive decline 
Medicare proposal to cover medical devices draws a mixed reaction 
Do masks work? RCTs can't tell us 
DIEP, the 'gold standard' of breast reconstruction, is under threat 
In Spain, a hospital brews its own CAR 
Duchenne breakthrough therapy leaves behind pioneering families 